General Information of the Compound
Compound ID
CP0341916
Compound Name
2-(1,3-benzodioxol-4-yloxy)-N-[[3-(cyclopenten-1-yl)phenyl]methyl]ethanamine
    Show/Hide
Structure
Formula
C21H23NO3
Molecular Weight
337.419
Canonical SMILES
C(COc1cccc2OCOc12)NCc1cccc(c1)C1=CCCC1
    Show/Hide
InChI
InChI=1S/C21H23NO3/c1-2-7-17(6-1)18-8-3-5-16(13-18)14-22-11-12-23-19-9-4-10-20-21(19)25-15-24-20/h3-6,8-10,13,22H,1-2,7,11-12,14-15H2
    Show/Hide
InChIKey
SHOKZDRFBVVMHZ-UHFFFAOYSA-N
Physicochemical Property
logP
4.1512
Rotatable Bonds
7
Heavy Atom Count
25
Polar Areas
39.72
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16109510
SID: 24756300
ChEMBL ID
CHEMBL441546
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 134.9 nM
   TI
   LI
   LO
   TS